Results 21 to 30 of about 28,042 (215)

Deep learning of ECG waveforms for diagnosis of heart failure with a reduced left ventricular ejection fraction

Scientific Reports, 2022
The performance and clinical implications of the deep learning aided algorithm using electrocardiogram of heart failure (HF) with reduced ejection fraction (DeepECG-HFrEF) were evaluated in patients with acute HF.
JungMin Choi, Sungjae Lee, Mineok Chang, Yeha Lee, Gyu Chul Oh, Hae-Young Lee   +5 more
doaj   +1 more source

Sequenced peptides constituting the HFrEF-related peptide panel and their differential excretion between HFrEF and Controls.

, 2016
Sequenced peptides constituting the HFrEF-related peptide panel and their differential excretion between HFrEF and Controls.
Helle Skovmand Bosselmann (2838521), Zhen-Yu Zhang (458621), Harald Mischak (103627), Jan A. Staessen (174667), Kasper Rossing (239382), Thomas Koeck (562347), Esther Nkuipou-Kenfack (562346), Tatiana Kuznetsova (1553629), Finn Gustafsson (797653), Yu-Mei Gu (802559), Morten Schou (2838518)   +10 more
core   +1 more source

ECG features for the three groups (HFpEF, HFmEF, and HFrEF).

, 2023
ECG features for the three groups (HFpEF, HFmEF, and HFrEF).
Stergios Soulaidopoulos (13824875), Sona M. Al Younis (17616243), Aamna M. Al Shehhi (17616246), Mohanad Alkhodari (11944473), Ahsan H. Khandoker (7039793), Konstantinos Tsioufis (3465620), Leontios J. Hadjileontiadis (4968052), Cesare Stefanini (9087917), Ioannis Doundoulakis (6564179), Petros Arsenos (17616249), Konstantinos A. Gatzoulis (17616252)   +10 more
core   +1 more source

HFrEF pharmacological treatment: diuretics

, 2018
Diuretics are an important part of the therapy for heart failure with reduced ejection fraction (HFrEF). These agents lead to amelioration of clinical symptoms and improvement in haemodynamics. There is little evidence, however, to support an association
Mariell Jessup, Rhondalyn Forde-McLean
core   +1 more source

HFrEF other treatment: revascularization

, 2018
Although coronary artery disease is the most common cause of heart failure with reduced ejection fraction (HFrEF), the role of revascularization as a treatment strategy to improve survival, reduce morbidity, and enhance the quality of life has only begun
Eric Velazquez, Mark C. Petrie
core   +1 more source

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes

ESC Heart Failure, 2023
Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF] 
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda   +11 more
doaj   +1 more source

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis

Brazilian Journal of Medical and Biological Research
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have symptoms and signs of HF with normal or near-normal left ventricular ejection fraction (LVEF ≥50%).
Chao Ma, Huan Luo, Lei Fan, Xiaoyan Liu, Chengshan Gao   +4 more
doaj   +1 more source

Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention

Frontiers in Cardiovascular Medicine, 2022
BackgroundChronic kidney disease (CKD) is very common in patients who are at a high risk of developing incident heart failure with reduced ejection fraction (HFrEF).
Wenguang Lai, Wenguang Lai, Wenguang Lai, Xiaoli Zhao, Sijia Yu, Sijia Yu, Sijia Yu, Ziling Mai, Ziling Mai, Ziling Mai, Yang Zhou, Yang Zhou, Zhidong Huang, Zhidong Huang, Qiang Li, Qiang Li, Haozhang Huang, Haozhang Huang, Haozhang Huang, Huanqiang Li, Huanqiang Li, Haiyan Wei, Dachuan Guo, Yun Xie, Yun Xie, Yun Xie, Shanggang Li, Shanggang Li, Hongyu Lu, Hongyu Lu, Jin Liu, Jin Liu, Shiqun Chen, Shiqun Chen, Yong Liu, Yong Liu, Yong Liu   +36 more
doaj   +1 more source

HFrEF pharmacological treatment: hydralazine and isosorbide dinitrate

, 2018
The use of hydralazine and isosorbide dinitrate in combination with renin–angiotensin blockade and evidence-based beta-blocker therapy is an accepted therapy for heart failure with reduced ejection fraction (HFrEF).
Clyde W. Yancy, Faraz S. Ahmad
core   +1 more source

Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities

AGING MEDICINE, EarlyView.
Mineralocorticoid receptor (MR) overactivation drives inflammation, oxidative stress, and fibrosis in the heart, kidneys, and vasculature, leading to cardiorenal dysfunction. MR signaling promotes hypertrophy, remodeling, and injury through pathways like oxidative stress and inflammation, resulting in vascular stiffness and progressive organ damage ...
Xiaoming Wang, Cuntai Zhang
wiley   +1 more source